Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlæge Jørgen Darling Jensen Holding ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5% 0.5%   Bankruptcy risk   2.4% 2.3% 2.8% 2.3% 1.6% 1.5% 9.3% 9.1%   Credit score (0-100)   65 66 59 63 73 75 26 27   Credit rating   BBB BBB BBB BBB A A BB BB   Credit limit (kDKK)   0.0 0.1 0.0 0.1 5.0 12.3 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   223 39 -8 -9 231 210 210 210   Gross profit   204 18.7 -29.8 -27.1 210 193 0.0 0.0   EBITDA   197 18.7 -29.8 -27.1 210 193 0.0 0.0   EBIT   197 18.7 -29.8 -27.1 210 193 0.0 0.0   Pre-tax profit (PTP)   -44.2 -105.1 -24.5 250.8 -72.2 375.1 0.0 0.0   Net earnings   -40.4 -101.2 -20.9 276.7 -5.3 337.7 0.0 0.0   Pre-tax profit without non-rec. items   -44.2 -105 -24.5 251 -72.2 375 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   3,599 3,390 3,259 3,422 3,302 3,522 3,129 3,129   Interest-bearing liabilities   0.0 0.0 0.0 0.0 55.7 23.0 0.0 0.0   Balance sheet total (assets)   3,619 3,410 3,279 3,442 3,378 3,630 3,129 3,129   Net Debt   -1,340 -1,635 -2,094 -2,294 -1,983 -2,320 -3,129 -3,129     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   223 39 -8 -9 231 210 210 210   Net sales growth   6.1% -82.4% -121.2% 13.8% -2,552.9% -9.4% 0.0% 0.0%   Gross profit   204 18.7 -29.8 -27.1 210 193 0.0 0.0   Gross profit growth   -67.7% -90.8% 0.0% 8.9% 0.0% -8.3% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,619 3,410 3,279 3,442 3,378 3,630 3,129 3,129   Balance sheet change%   -3.9% -5.8% -3.9% 5.0% -1.9% 7.5% -13.8% 0.0%   Added value   196.6 18.7 -29.8 -27.1 210.0 192.7 0.0 0.0   Added value %   88.1% 47.7% 359.5% 287.7% 90.7% 91.9% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   1.0 -1.0 -2.0 1.0 -1.0 -2.0 0.0 0.0   EBIT trend   2.0 3.0 -1.0 -2.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   88.1% 47.7% 359.5% 287.7% 90.7% 91.9% 0.0% 0.0%   EBIT %   88.1% 47.7% 0.0% 0.0% 90.7% 91.9% 0.0% 0.0%   EBIT to gross profit (%)   96.3% 100.0% 100.0% 100.0% 100.0% 100.0% 0.0% 0.0%   Net Earnings %   -18.1% -258.2% 252.6% -2,932.6% -2.3% 161.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   -18.1% -258.2% 252.6% -2,932.6% -2.3% 161.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   -19.8% -268.2% 295.9% -2,658.1% -31.2% 178.9% 0.0% 0.0%   ROA %   5.8% 0.7% -0.4% 7.5% 6.2% 10.9% 0.0% 0.0%   ROI %   5.8% 0.7% -0.4% 7.5% 6.2% 11.1% 0.0% 0.0%   ROE %   -1.1% -2.9% -0.6% 8.3% -0.2% 9.9% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   99.4% 99.4% 99.4% 99.4% 97.8% 97.0% 100.0% 100.0%   Relative indebtedness %   9.0% 51.0% -241.2% -212.0% 32.7% 51.6% 0.0% 0.0%   Relative net indebtedness %   -591.2% -4,121.0% 25,014.4% 24,100.6% -848.2% -1,066.0% -1,492.3% -1,492.3%   Net int. bear. debt to EBITDA, %   -681.5% -8,752.4% 7,025.9% 8,451.4% -944.5% -1,204.4% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 1.7% 0.7% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 1,014.3% 18.3% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   122.0 119.5 113.4 122.0 28.4 22.2 0.0 0.0   Current Ratio   122.0 119.5 113.4 122.0 28.4 22.2 0.0 0.0   Cash and cash equivalent   1,339.8 1,635.2 2,093.9 2,294.1 2,038.9 2,343.2 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 -0.0 -0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   198.9 294.4 339.3 412.2 340.0 428.7 0.0 0.0   Current assets / Net sales %   1,092.6% 6,099.9% -27,350.2% -25,866.4% 926.8% 1,145.7% 1,492.3% 1,492.3%   Net working capital   2,419.2 2,370.8 234.2 219.6 148.7 184.4 0.0 0.0   Net working capital %   1,083.6% 6,048.9% -2,824.5% -2,326.8% 64.3% 87.9% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   223 39 -8 -9 231 210 0 0   Added value / employee   197 19 -30 -27 210 193 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   197 19 -30 -27 210 193 0 0   EBIT / employee   197 19 -30 -27 210 193 0 0   Net earnings / employee   -40 -101 -21 277 -5 338 0 0